BALANCE SHEETS - USD ($)	Sep. 30, 2018	Sep. 30, 2017
CURRENT ASSETS:
Cash and cash equivalents	$ 10,310,044	$ 2,369,438
Receivables	118,657	218,481
Prepaid expenses	364,622	826,429
Deposits - current portion	0	150,000
Inventory used for R&D and manufacturing	645,238	672,522
Total current assets	11,438,561	4,236,870
Plant, property and equipment	16,218,851	16,793,220
Patent costs, net	258,093	223,167
Deposits	1,670,917	1,670,917
Total Assets	29,586,422	22,924,174
CURRENT LIABILITIES:
Accounts payable	5,743,913	8,196,334
Accrued expenses	205,310	936,698
Due to employees	764,941	693,831
Notes payable, net of discounts	0	994,258
Derivative instruments, current portion	2,498,606	10,984
Other current liabilities	14,029	12,449
Total current liabilities	9,226,799	10,844,554
Derivative instruments, net of current portion	6,818,458	2,042,418
Lease liability	13,379,962	13,211,925
Deferred revenue	126,795	125,000
Other liabilities	33,492	37,254
Total liabilities	29,585,506	26,261,151
COMMITMENTS AND CONTINGENCIES
STOCKHOLDERS' EQUITY (DEFICIT)
Preferred stock, $.01 par value- 200,000 shares authorized; -0- shares issued and outstanding	0	0
Common stock, $.01 par value - 600,000,000 shares authorized; 28,034,487 and 11,903,133 shares issued and outstanding at September 30, 2018 and 2017, respectively	280,346	119,031
Additional paid-in capital	331,312,184	296,298,401
Accumulated deficit	(331,591,614)	(299,754,409)
Total stockholders' equity (deficit)	916	(3,336,977)
TOTAL LIABILITIES AND STOCKHOLDERS' (DEFICIT) EQUITY	$ 29,586,422	$ 22,924,174